Literature DB >> 3412584

Erectile dysfunction in multiple sclerosis.

H J Kirkeby1, E U Poulsen, T Petersen, J Dørup.   

Abstract

In a sample of 29 impotent men with multiple sclerosis and erectile problems, penile arterial inflow and venous outflow were within normal limits. In 26 patients, the pudendal evoked potential (PEP) was abnormal, and eight of these also had abnormal bulbocavernous reflex (BCR). Three patients had abnormal PEP and normal BCR, and of these, two had normal and one had abnormal nocturnal erectile activity. The validity of PEP/BCR testing was supported by normal findings in six patients with MS and without erectile problems. Nocturnal erectile activity was normal in 11 patients, of whom nine had abnormal PEP and/or BCR. A high disability score corresponded poorly with both reduced sexual function, insufficient nocturnal erectile activity, and abnormal PEP and/or BCR. Intracavernous injection of papaverine gave erection in 27 patients, the dose needed to create an erection being inversely related to the level of disablement. PEP and BCR testing may be more sensitive in defining neurogenic erectile dysfunction (ED) than nocturnal erectile activity. We considered 26 of the cases to have a neurogenic cause of ED and three to have mainly a psychogenic cause.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3412584     DOI: 10.1212/wnl.38.9.1366

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Multiple Sclerosis: Symptomatic Treatment.

Authors:  C T Bever
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  [Influence of neurological diseases on partnership and sexuality. Particularly in view of multiple sclerosis and Parkinson's disease].

Authors:  D Goecker; D Rösing; K M Beier
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

Review 3.  Neurophysiology of the pelvic floor in clinical practice: a systematic literature review.

Authors:  Fiorella Bianchi; Giovanna M Squintani; M Osio; A Morini; C Bana; G Ardolino; S Barbieri; L Bertolasi; R Caramelli; F Cogiamanian; A Currà; G de Scisciolo; C Foresti; V Frasca; E Frasson; M Inghilleri; L Maderna; L Motti; E Onesti; M C Romano; U Del Carro
Journal:  Funct Neurol       Date:  2017 Oct/Dec

4.  A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis.

Authors:  C J Fowler; J R Miller; M K Sharief; I F Hussain; V J Stecher; M Sweeney
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 5.  Investigation of the neurogenic bladder.

Authors:  C J Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

6.  Sexual function in multiple sclerosis. A 5-year follow-up study.

Authors:  E Stenager; E N Stenager; K Jensen
Journal:  Ital J Neurol Sci       Date:  1996-02

7.  Comparison of nocturnal penile tumescence monitoring and cavernosal smooth muscle content in patients with erectile dysfunction.

Authors:  Erdal Yilmaz; Onder Yaman; Murat Bozlu; Tansel Inal; Zafer Tokatli; Kadri Anafarta
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 8.  Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies.

Authors:  Ranan DasGupta; Clare J Fowler
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  The treatment of erectile dysfunction in patients with neurogenic disease.

Authors:  Anand N Shridharani; William O Brant
Journal:  Transl Androl Urol       Date:  2016-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.